DAWN icon

Day One Biopharmaceuticals
DAWN

Overview Fund Activity

93 hedge funds and large institutions have $1.19B invested in Day One Biopharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 18 reducing their positions, and 17 closing their positions.

Holders
93
Holders Change
+6
Holders Change %
+6.9%
% of All Funds
1.61%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.09%
New
24
Increased
36
Reduced
18
Closed
17
Calls
$2.88M
Puts
$4.07M
Net Calls
-$1.19M
Net Calls Change
-$6.32M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$176M
2
State Street
2
State Street
Massachusetts
$40.9M
3
NIP
3
Nicholas Investment Partners
California
$15.2M
4
BlackRock
4
BlackRock
New York
$50.9M
5
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$10.1M

Top Sellers

1
CPX
1
Canaan Partners XI
California
$139M
2
DM
2
Deerfield Management
New York
$20.7M
3
AVLSA
3
Atlas Venture Life Science Advisors
Massachusetts
$164M
4
PA
4
Perceptive Advisors
New York
$0
5
Viking Global Investors
5
Viking Global Investors
Connecticut
$31.2M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$176M 8,791,491 +1,964,917 +29%
AVLSA
2
Atlas Venture Life Science Advisors
Massachusetts
$164M 8,169,171 -799,134 -9%
RCM
3
RA Capital Management
Massachusetts
$141M 7,040,622 – –
CPX
4
Canaan Partners XI
California
$139M 6,964,301 -2,699,344 -28%
Adage Capital Partners
5
Adage Capital Partners
Massachusetts
$60.9M 3,040,000 +293,175 +11%
Vanguard Group
6
Vanguard Group
Pennsylvania
$52.4M 2,615,441 -11,033 -0.4%
BlackRock
7
BlackRock
New York
$50.9M 2,541,235 +578,511 +29%
Franklin Resources
8
Franklin Resources
California
$49.6M 2,476,706 +11,326 +0.5%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$42M 2,094,913 +53,569 +3%
State Street
10
State Street
Massachusetts
$40.9M 2,041,738 +1,682,955 +469%
Goldman Sachs
11
Goldman Sachs
New York
$34.6M 1,725,142 -169,395 -9%
Viking Global Investors
12
Viking Global Investors
Connecticut
$31.2M 1,558,563 -298,861 -16%
BC
13
Boxer Capital
California
$23.8M 1,189,943 – –
DM
14
Deerfield Management
New York
$20.7M 1,032,000 -2,480,123 -71%
NIP
15
Nicholas Investment Partners
California
$15.2M 757,407 +757,407 New
CC
16
Commodore Capital
New York
$14.8M 739,661 – –
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
$11.4M 567,148 +428,830 +310%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$11.1M 554,630 +112,271 +25%
Lord, Abbett & Co
19
Lord, Abbett & Co
New Jersey
$10.1M 504,251 +504,251 New
DCM
20
Driehaus Capital Management
Illinois
$9.81M 489,972 -11,717 -2%
PCM
21
Pathway Capital Management
California
$8.08M 403,127 +403,127 New
TCM
22
Tang Capital Management
California
$8.01M 400,000 +400,000 New
Northern Trust
23
Northern Trust
Illinois
$4.51M 225,050 +34,540 +18%
PHP
24
Parkman Healthcare Partners
Connecticut
$4.25M 212,191 +97,441 +85%
Voloridge Investment Management
25
Voloridge Investment Management
Florida
$4.15M 207,265 +207,265 New
1
2 3 4 5